{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:41:12Z","timestamp":1775108472965,"version":"3.50.1"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mitochondrial permeability transition-driven necrosis (MPT-DN) is a therapeutic target and critical driver of prostate adenocarcinoma (PRAD) progression. We investigated MPT-DN-related prognostic features in PRAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PRAD transcriptomics and MPT-DN-RGs were sourced from public databases. WGCNA, differential expression, Cox regression, and machine learning identified BCR-FS prognostic genes. These genes built a risk model, revealing independent prognostic factors. Patients were stratified into high\/low-risk groups. Pathways, immune microenvironment, and drug sensitivities were analyzed between groups. Finally, protein expression was validated in PCa versus normal tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TREM2, FNDC1, and S100A8 were identified as prognostic genes. The developed risk model demonstrated strong predictive capabilities in BCR-FS, and subsequent analysis confirmed risk score, Gleason, T stage, and prostate specific antigen (PSA) as independent prognostic factors. The majority of the enrichment pathways in the high-risk group (HRG) and low-risk group (LRG) were related to the metabolism. Moreover, it was found that HRG and LRG displayed distinct immune landscapes, with HRG exhibiting immune exclusion and stronger immune evasion capabilities. Lastly, analysis of drug sensitivity showed significant differences for 6 drugs, with all values being lower in the HRG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identified TREM2, FNDC1, and S100A8 as key MPT-driven necrosis-related genes predicting biochemical recurrence in PRAD. The risk model effectively stratified patients, revealing immune exclusion and drug resistance in high-risk cases, offering prognostic and therapeutic insights.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1775602","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:15:11Z","timestamp":1775103311000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel prognostic signature based on mitochondrial permeability transition-driven necrosis genes for biochemical recurrence prediction in prostate cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Xing","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University)","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyu","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University)","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University)","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinggui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University)","place":["Chongqing, China"]},{"name":"School of Medicine, Chongqing University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University)","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingzheng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University)","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University)","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University)","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University)","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University)","place":["Chongqing, China"]},{"name":"State Key Laboratory of Trauma and Chemical Poisoning, Third Military Medical University (Army Medical University)","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.32900","article-title":"Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy","volume":"6","author":"Falagario","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1606220","article-title":"10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2025.106738","article-title":"LYVE1 and IL1RL1 are mitochondrial permeability transition-driven necrosis-related genes in heart failure","volume":"180","author":"Zheng","year":"2025","journal-title":"Int J Biochem Cell Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17406","DOI":"10.1038\/s41598-024-65990-6","article-title":"lncRNA signature mediates mitochondrial permeability transition-driven necrosis in regulating the tumor immune microenvironment of cervical cancer","volume":"14","author":"Yi","year":"2024","journal-title":"Sci Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2023.03.020","article-title":"Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive oxygen species induction","volume":"202","author":"Xiao","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40001-025-02370-4","article-title":"Identification and multi-dimensional validation of mitochondrial permeability transition-driven necrosis-related model to assess the prognosis and immunotherapy value in breast cancer","volume":"30","author":"Liu","year":"2025","journal-title":"Eur J Med Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41420-024-01947-y","article-title":"Nano-flow cytometry unveils mitochondrial permeability transition process and multi-pathway cell death induction for cancer therapy","volume":"10","author":"Su","year":"2024","journal-title":"Cell Death Discov"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/gtmb.2022.0141","article-title":"Identifying mitochondrial transcription factor A as a potential biomarker for the carcinogenesis and prognosis of prostate cancer","volume":"27","author":"Tian","year":"2023","journal-title":"Genet Test Mol Biomarkers"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054482","article-title":"Mitochondrial alterations in prostate cancer: Roles in pathobiology and racial disparities","volume":"24","author":"Vikramdeo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101670","article-title":"A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer","volume":"33","author":"Lu","year":"2023","journal-title":"Transl Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1009634","article-title":"The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yjmcc.2022.11.003","article-title":"Mitochondrial permeability transition pore-dependent necrosis","volume":"174","author":"Robichaux","year":"2023","journal-title":"J Mol Cell Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1018639","article-title":"Identification of hub genes for early detection of bone metastasis in breast cancer","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-023-01868-8","article-title":"Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy","volume":"28","author":"Shi","year":"2023","journal-title":"Apoptosis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2022.01.013","article-title":"An Euler proportional Venn diagram of obstructive lung disease","volume":"58","author":"Soriano","year":"2022","journal-title":"Arch Bronconeumol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s10020-022-00504-6","article-title":"The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma","volume":"28","author":"Gu","year":"2022","journal-title":"Mol Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12935-022-02622-x","article-title":"Thrombospondin-2 acts as a bridge between tumor extracellular matrix and immune infiltration in pancreatic and stomach adenocarcinomas: an integrative pan-cancer analysis","volume":"22","author":"Liao","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1181370","article-title":"The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma","volume":"14","author":"Yao","year":"2023","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2250987","article-title":"Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer","volume":"55","author":"Huang","year":"2023","journal-title":"Ann Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.946637","article-title":"EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort","volume":"13","author":"Ge","year":"2022","journal-title":"Front Pharmacol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.982267","article-title":"Computer classification and construction of a novel prognostic signature based on moonlighting genes in prostate cancer","volume":"12","author":"Mei","year":"2022","journal-title":"Front Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s462951","article-title":"Application of chest CT imaging feature model in distinguishing squamous cell carcinoma and adenocarcinoma of the lung","volume":"16","author":"Liu","year":"2024","journal-title":"Cancer Manag Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5517786","article-title":"Dysregulated circulating apoptosis- and autophagy-related lncRNAs as diagnostic markers in coronary artery disease","volume":"2021","author":"Zhang","year":"2021","journal-title":"BioMed Res Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.13345\/j.cjb.210676","article-title":"Predicting tumor drug sensitivity with multi-omics data","volume":"38","author":"Yang","year":"2022","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Brief Bioinform"},{"key":"B36","doi-asserted-by":"publisher","first-page":"115047","DOI":"10.2139\/ssrn.4012384","article-title":"Activation of CXCL13\/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis\/bladder pain syndrome","volume":"200","author":"Zhao","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s239407","article-title":"DUSP9 suppresses proliferation and migration of clear cell renal cell carcinoma via the mTOR pathway","volume":"13","author":"Luo","year":"2020","journal-title":"Onco Targets Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/srep19670","article-title":"The c-Jun N-terminal kinase (JNK) pathway is activated in human interstitial cystitis (IC) and rat protamine sulfate induced cystitis","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.869759","article-title":"Roles of m5C RNA modification patterns in biochemical recurrence and tumor microenvironment characterization of prostate adenocarcinoma","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-24-1442","article-title":"Mitochondrial permeability transition drives the expression, identification and validation of necrosis-related genes in prognostic risk models of hepatocellular carcinoma","volume":"14","author":"Jin","year":"2025","journal-title":"Transl Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-024-01693-7","article-title":"Integrating bioinformatics and experimental validation to identify mitochondrial permeability transition-driven necrosis-related lncRNAs that can serve as prognostic biomarkers and therapeutic targets in endometrial carcinoma","volume":"32","author":"Zhou","year":"2025","journal-title":"Reprod Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41065-025-00379-7","article-title":"Identification of prognostic biomarker of non-small cell lung cancer based on mitochondrial permeability transition-driven necrosis-related genes and determination of anti-tumor effect of ARL14","volume":"162","author":"Ma","year":"2025","journal-title":"Hereditas"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13020060","article-title":"TREM2 alleviates neuroinflammation by maintaining cellular metabolic homeostasis and mitophagy activity during early inflammation","volume":"13","author":"Hu","year":"2025","journal-title":"Diseases"},{"key":"B44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41419-024-06579-9","article-title":"TREM2 deficiency impairs the energy metabolism of Schwann cells and exacerbates peripheral neurological deficits","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2020-0521oc","article-title":"TREM2 dictates antibacterial defense and viability of bone marrow-derived macrophages during bacterial infection","volume":"65","author":"Yang","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1089266","article-title":"TREM2 is associated with tumor immunity and implies poor prognosis in glioma","volume":"13","author":"Yu","year":"2022","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10608-y","article-title":"TREM2 as an independent predictor of poor prognosis promotes the migration via the PI3K\/AKT axis in prostate cancer","volume":"15","author":"Gao","year":"2023","journal-title":"Am J Transl Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.032","article-title":"TREM2(+) macrophages suppress CD8(+) T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma","volume":"79","author":"Tan","year":"2023","journal-title":"J Hepatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109844","article-title":"Targeting TREM2 on tumor-associated macrophages enhances immunotherapy","volume":"37","author":"Binnewies","year":"2021","journal-title":"Cell Rep"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2021.1872885","article-title":"Fndc-1-mediated mitophagy and ATFS-1 coordinate to protect against hypoxia-reoxygenation","volume":"17","author":"Lim","year":"2021","journal-title":"Autophagy"},{"key":"B52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ydbio.2019.06.016","article-title":"Fndc-1 contributes to paternal mitochondria elimination in C. elegans","volume":"454","author":"Lim","year":"2019","journal-title":"Dev Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101953","article-title":"Investigation of the pan-cancer property of FNDC1 and its molecular mechanism to promote lung adenocarcinoma metastasis","volume":"44","author":"Song","year":"2024","journal-title":"Transl Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbrc.2022.02.038","article-title":"Up-regulated FNDC1 accelerates stemness and chemoradiation resistance in colorectal cancer cells","volume":"602","author":"Chen","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1005695","article-title":"Identification of prognostic immune-related lncRNAs in pancreatic cancer","volume":"13","author":"Ma","year":"2022","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.yexcr.2016.09.021","article-title":"MiR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1\/fibronectin","volume":"348","author":"Das","year":"2016","journal-title":"Exp Cell Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188891","article-title":"S100A8 and S100A9 in cancer","volume":"1878","author":"Chen","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01298","article-title":"S100A8\/A9 in inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223579","article-title":"S100A8-mediated NLRP3 inflammasome-dependent pyroptosis in macrophages facilitates liver fibrosis progression","volume":"11","author":"Liu","year":"2022","journal-title":"Cells"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.118.039262","article-title":"S100a8\/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic\/reperfusion injury","volume":"140","author":"Li","year":"2019","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/b978-0-323-85666-9.00016-4","article-title":"S100A8\/A9(hi) neutrophils induce mitochondrial dysfunction and PANoptosis in endothelial cells via mitochondrial complex I deficiency during sepsis","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109716","article-title":"S100a8\/a9 contributes to sepsis-induced cardiomyopathy by activating ERK1\/2-Drp1-mediated mitochondrial fission and respiratory dysfunction","volume":"115","author":"Wu","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12130","article-title":"S100A8 promotes epithelial-mesenchymal transition and metastasis under TGF-beta\/USF2 axis in colorectal cancer","volume":"41","author":"Li","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900753","article-title":"Proinflammatory S100A8 induces PD-L1 expression in macrophages, mediating tumor immune escape","volume":"204","author":"Li","year":"2020","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4194-4","article-title":"Comparison of mRNA, protein, and urinary nucleic acid levels of S100A8 and S100A9 between prostate cancer and BPH","volume":"22","author":"Yun","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.cmet.2020.04.007","article-title":"Developmental and tumor angiogenesis requires the mitochondria-shaping protein Opa1","volume":"31","author":"Herkenne","year":"2020","journal-title":"Cell Metab"},{"key":"B67","doi-asserted-by":"publisher","first-page":"14178","DOI":"10.1038\/s41598-024-64228-9","article-title":"Mitochondrial division inhibitor (mdivi-1) induces extracellular matrix (ECM)-detachment of viable breast cancer cells by a DRP1-independent mechanism","volume":"14","author":"Silva-Pavez","year":"2024","journal-title":"Sci Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1775602\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:15:15Z","timestamp":1775103315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1775602\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":67,"alternative-id":["10.3389\/fonc.2026.1775602"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1775602","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"article-number":"1775602"}}